Skip to main content
SpringerLink
Log in
Book cover

Anaesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E. pp 465–477Cite as

Myasthenia Gravis

  • Conference paper

  • 184 Accesses

Abstract

Myasthenia Gravis (MG) is an autoimmune disease, resulting from the production of antibodies against the acetylcholine receptors (AChRs) of the endplate. The essential clinical feature of MG is a fluctuant weakness of voluntary muscles, mostly those innervated by cranial nerves; its incidence is about 1 in every 20,000 adults and is age- and sex-related, with one peak in the second and third decades affecting mostly women and a second peak in the sixth and seventh decades affecting mostly men [1].

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baraka A (1992) Anaesthesia and myasthenia gravis. Can J Anaesth 39:476–466

    Article  PubMed  CAS  Google Scholar 

  2. Long RR (1991) Myasthenia gravis in the intensive care unit. In: Rippe JM, Irwin RS, Alpert J et al (ed) Intensive care medicine. Little, Brown and Company, Boston Toronto London, pp 1596–1601

    Google Scholar 

  3. Grob D, Arsura EL, Brunner NG et al (1987) The course of myasthenia gravis and therapies affecting outcome. Ann NY Acad Sci 505:472–499

    Article  PubMed  CAS  Google Scholar 

  4. Derdak S (1988) Myasthenia gravis. In: Civetta JM, Taylor RW, Kyrby RR (ed) Critical care. JB Lippincott Company, Philadelphia, pp 1257–1260

    Google Scholar 

  5. Engel AG (1987) Myasthenia gravis and other disorders of neuromuscular transmission. In: Braunwald E, Isselbacher KJ, Petersdorf RG et al (ed) Harrison’s Principles of internal medicine. McGraw-Hill Book Company, New York, pp 2079–2082

    Google Scholar 

  6. Osserman KE, Genkins G (1971) Studies on myasthenia gravis. Review of a twenty-year experience in over 1200 patients. M Sinai J M 38:497–537

    CAS  Google Scholar 

  7. Drachman DB (1994) Myasthenia gravis. N Engl J Med 330:1797–1810

    Article  PubMed  CAS  Google Scholar 

  8. Drachman DB (1978) Myasthenia gravis. N Engl J Med 298:136–142

    Article  PubMed  CAS  Google Scholar 

  9. Lindstrom JM, Seybold ME, Lenon VA et al (1976) Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology 26: 1054–1059

    Article  PubMed  CAS  Google Scholar 

  10. Pestronk A, Drachman DB, Self SG (1985) Measurement of junctional acetylcoline receptors in myasthenia gravis: clinical correlates. Muscle Nerve 8:245–251

    Article  PubMed  CAS  Google Scholar 

  11. Engel AG, Tsujihata M, Lindstrom JM et al (1976) The motor end-plate in myasthenia gravis and in experimental autoimmune myasthenia gravis: a quantitative ultrastructural study. Ann NY Acad Sci 274:60–79

    Article  PubMed  CAS  Google Scholar 

  12. Bowman WC (1980) Prejunctional and postjunctional cholinoceptors at the neuromuscular junction. Anesth Analg 59:935–943

    Article  PubMed  CAS  Google Scholar 

  13. Woolf AL (1966) Morphology of the myasthenic neuromuscular junction. Ann NY Acad Sci 135:33–58

    Article  Google Scholar 

  14. Sanders DB (1987) The electrodiagnosis of myasthenia gravis. Ann NY Acad Sci 505: 539–555

    Article  PubMed  CAS  Google Scholar 

  15. Vincent A, Newsom-Davis J (1985) Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry 48:1246–1252

    Article  PubMed  CAS  Google Scholar 

  16. Drachman DB, De Silva S, Ramsay D et al (1987) Humoral pathogenesis of myasthenia gravis. Ann NY Acad Sci 505:90–104

    Article  PubMed  CAS  Google Scholar 

  17. Toyka KV, Drachman DB, Griffin DE et al (1977) Myasthenia gravis: study of humoral immune mechanisms by passive transfer to mice. N Engl J Med 296:125–131

    Article  PubMed  CAS  Google Scholar 

  18. Lambert EH, Lindstrom JM, Lennon VA (1976) End-plate potentials in experimental autoimmune myasthenia gravis in rats. Ann NY Acad Sci 274:300–318

    Article  PubMed  CAS  Google Scholar 

  19. Penn AS, Chang HW, Lovelace RE et al (1976) Antibodies to acetylcholine receptors in rabbits: immunochemical and electrophisiological studies. Ann NY Acad Sci 274:354–376

    Article  PubMed  CAS  Google Scholar 

  20. Drachman DB, Adams RN, Josifek LF et al (1982) Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N Engl J Med 307: 769–775

    Article  PubMed  CAS  Google Scholar 

  21. Vincent A, Whiting PJ, Schluep M et al (1987) Antibody heterogeneity and specifity in myasthenia gravis. Ann NY Acad Sci 505:326–332

    Article  Google Scholar 

  22. Howard FM jr, Lennon VA, Finley J et al (1987) Clinical correlation of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis. Ann NY Acad Sci 505:526–538

    Article  PubMed  Google Scholar 

  23. Mossman S, Vincent A, Newsom-Davis J (1986) Myasthenia gravis without acetylcholine receptor antibody: a distinct disease entity. Lancet 1:116–119

    Article  PubMed  CAS  Google Scholar 

  24. Brooks EB, Pachner AR, Drachman DB et al (1990) A sensitive rosetting assay for detection of acetylcholine receptor antibodies using BC3H-1 cells: positive results in “antibody negative” myasthenia gravis. J Neuroimmunol 28:83–93

    Article  PubMed  CAS  Google Scholar 

  25. Yamamoto T, Vincent A, Ciulla TA et al (1991) Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM. Ann Neurol 30:550–557

    Article  PubMed  CAS  Google Scholar 

  26. Berrih-Aknin S, Morel E, Raimond F et al (1987) The role of the thymus in myasthenia gravis: immunohistological and immunological studies in 115 cases. Ann NY Acad Sci 505: 50–70

    Article  PubMed  CAS  Google Scholar 

  27. Moiola L, Protti MP, Manfredi AA et al (1993) T- helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis. Ann NY Acad Sci 505: 198–218

    Article  Google Scholar 

  28. Ozdemir C, Young RR (1976) The results to be expected from electrical testing in the diagnosis of myasthenia gravis. Ann NY Acad Sci 274:203–222

    Article  PubMed  CAS  Google Scholar 

  29. Kim YI (1987) Lambert-Eaton myasthenic syndrome: evidence for calcium channel blockade. Ann NY Acad Sci 505:377–379

    Article  PubMed  CAS  Google Scholar 

  30. Grob D, Brunner NG, Namba T (1981) The natural course of myasthenia gravis and effect of therapeutic measures. Ann NY Acad Sci 377:652–669

    Article  PubMed  CAS  Google Scholar 

  31. Kirsch JR, Diringer NM, Borel CO et al (1991) Preoperative lumbar epidural morphine improves postoperative analgesia and ventilatory function after transsternal thymectomy in patients with myasthenia gravis. Crit Care Med 19:1474–1479

    Article  PubMed  CAS  Google Scholar 

  32. Kao I, Drachman DB (1977) Thymic muscle cells bear acetylcholine receptors: possible relation to myasthenia gravis. Science 195:74–75

    Article  PubMed  CAS  Google Scholar 

  33. Wheatley LM, Urso D, Tumas K et al (1992) Molecular evidence for the expression of nicotinic acetylcholine receptor a-chain in mouse thymus. J Immunol 148:3105–3109

    PubMed  CAS  Google Scholar 

  34. Johns TR (1987) Long-term corticosteroid treatment of myasthenia gravis. Ann NY Acad Sci 505:568–583

    Article  PubMed  CAS  Google Scholar 

  35. Van Wilgenburg H (1979) The effect of prednisolone on neuromuscular transmission in the rat diaphragm. Eur J Pharmacol 55:355–361

    Article  PubMed  Google Scholar 

  36. Tindall RSA, Phillips JT, Rollins JA et al (1993) A clinical therapeutic trial of cyclosporine in myasthenia gravis. Ann NY Acad Sci 681:539–551

    Article  PubMed  CAS  Google Scholar 

  37. Schalke BCG, Kappos L, Rohrbach E et al (1988) Cyclosporine A vs azathioprine in the treatment of myasthenia gravis: final results of a randomized, controlled double blind clinical trial. Neurology 38[Suppl 1]:135.

    Google Scholar 

  38. Pinching AJ, Peters DK, Newsom-Davis J (1976) Remission of myasthenia gravis following plasma-exchange. Lancet 2:1373–1376

    Article  PubMed  CAS  Google Scholar 

  39. Keesey J, Buffklin D, Kebo D et al (1981) Plasma exchange alone as therapy for myasthenia gravis. Ann NY Acad Sci 377:729–743

    Article  PubMed  CAS  Google Scholar 

  40. Reimann PM, Mason PD (1990) Plasmapheresis: technique and complications. Intensive Care Med 16:3–10

    Article  PubMed  CAS  Google Scholar 

  41. Genkins G, Sivak M, Tartter P (1993) Treatment strategies in myasthenia gravis. Ann NY Acad Sci 681:603–608

    Article  PubMed  CAS  Google Scholar 

  42. Drachman DB, McIntosh KR, Reim J et al (1993) Strategies for treatment of myasthenia gravis. Ann NY Acad Sci 681:515–528

    Article  PubMed  CAS  Google Scholar 

  43. Killen JA, Lindstrom JM (1984) Specific killing of lymphocytes that causes experimental autoimmune myasthenia gravis by ricin toxin-acetylcholine receptor conjugates. J Immunol 133:2549–2553

    PubMed  CAS  Google Scholar 

  44. Sterz RK, Biro G, Filipp G et al (1985) Experimental autoimmune myasthenia gravis: can pretreatment with I-125-labeled receptor prevent functional damage at the neuromuscular iunction? J Immunol 134:841–846

    PubMed  CAS  Google Scholar 

  45. Waldmann TA (1986) The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes. Science 232:727–732

    Article  PubMed  CAS  Google Scholar 

  46. Balcer LJ, McIntosh KR, Nichols JC et al (1991) Suppression of immune responses to acetylcholine receptor by interleukin-2 fusion toxin: in vivo and in vitro studies. J Neuroimmunol 31:115–122

    Article  PubMed  CAS  Google Scholar 

  47. Weiner HL, Zhang ZJ, Khoury SJ et al (1991) Antigen-driven peripheral immune tolerance: suppression of organ-specific autoimmune diseases by oral administration of autoantigens. Ann NY Acad Sci 636:227–232

    Article  PubMed  CAS  Google Scholar 

  48. Wang ZY, Qiao J, Link H (1993) Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor. J Neuroimmunol 44:209–214

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. E. Facco
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Gallo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. M. Volpin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Anaesthesiology and Intensive Care, Trieste University School of Medicine, Trieste, Italy

    Antonino Gullo M.D. (Head) (Head)

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Italia

About this paper

Cite this paper

Facco, E., Gallo, F., Volpin, S.M. (1997). Myasthenia Gravis. In: Gullo, A. (eds) Anaesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E.. Springer, Milano. https://doi.org/10.1007/978-88-470-2296-6_41

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2296-6_41

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-3-540-75032-1

  • Online ISBN: 978-88-470-2296-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation